Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed
出版年份 2015 全文链接
标题
Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 41, Issue 7, Pages 613-623
出版商
Wiley
发表日期
2015-02-05
DOI
10.1111/apt.13083
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial
- (2016) Remo Panaccione et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis
- (2014) F. Baert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mucosal healing in pediatric Crohn’s disease after anti-TNF therapy
- (2014) Stefano Nobile et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Crohn's disease outpatients treated with adalimumab have an earlier secondary loss of response and requirement for dose escalation compared to infliximab: A real life cohort study
- (2014) Christopher Ma et al. Journal of Crohns & Colitis
- Adalimumab for Crohn's disease: Long-term sustained benefit in a population-based cohort of 438 patients
- (2014) Charlotte P. Peters et al. Journal of Crohns & Colitis
- Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease Cohort
- (2014) Philippe Hiroz et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Mechanism and Therapeutic Strategy of Secondary Failure to Anti-Tumor Necrosis Factor-a Monoclonal Antibody Treatment for Crohn's Disease
- (2013) Katsuyoshi Matsuoka et al. DIGESTION
- Adalimumab in active ulcerative colitis: A “real-life” observational study
- (2013) Alessandro Armuzzi et al. DIGESTIVE AND LIVER DISEASE
- Adalimumab for Crohn’s disease after infliximab treatment failure
- (2013) Wei Da et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Effects of Infliximab Retreatment After Consecutive Discontinuation of Infliximab and Adalimumab in Refractory Crohnʼs Disease
- (2013) Johannan F. Brandse et al. INFLAMMATORY BOWEL DISEASES
- Comparative Effectiveness of Anti-TNF Agents for Crohn’s Disease in a Tertiary Referral IBD Practice
- (2012) Seema A. Patil et al. DIGESTIVE DISEASES AND SCIENCES
- Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab
- (2012) Manuel Barreiro-de Acosta et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial
- (2012) Edouard Louis et al. Journal of Crohns & Colitis
- Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome
- (2012) Orlando García-Bosch et al. Journal of Crohns & Colitis
- Efficacy of adalimumab in patients with crohn's disease and failure to infliximab therapy: a clinical series
- (2012) Patricia Cordero-Ruiz et al. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
- Review article: causative factors and the clinical management of patients with Crohn’s disease who lose response to anti-TNF-α therapy
- (2011) S. Danese et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn’s disease with prior loss of response to infliximab
- (2011) B. G. Feagan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: loss of response to anti-TNF treatments in Crohn’s disease
- (2011) S. Ben-Horin et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease
- (2011) L. S. Kiss et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Loss of Response and Need for Adalimumab Dose Intensification in Crohn's Disease: A Systematic Review
- (2011) Vincent Billioud et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Infliximab-Induced Autoimmune Hepatitis with Successful Switch to Adalimumab in a Patient with Crohn’s disease: The Index Case
- (2011) Dahlia A. Goldfeld et al. DIGESTIVE DISEASES AND SCIENCES
- Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience
- (2011) José Ignacio Fortea-Ormaechea et al. Gastroenterologia y Hepatologia
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- Trough Levels and Antibodies to Infliximab May Not Predict Response to Intensification of Infliximab Therapy in Patients With Inflammatory Bowel Disease
- (2011) Benjamin Pariente et al. INFLAMMATORY BOWEL DISEASES
- Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohnʼs disease: Results from CARE
- (2011) Robert Löfberg et al. INFLAMMATORY BOWEL DISEASES
- Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience
- (2011) Michael B. Sprakes et al. Journal of Crohns & Colitis
- Clinical trial: impact of prior infliximab therapy on the clinical response to certolizumab pegol maintenance therapy for Crohn’s disease
- (2010) S. B. Hanauer et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy
- (2010) S. Lichtiger et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab
- (2010) C. Taxonera et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab
- (2010) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- “How to Manage Loss of Response to Anti-TNF in Crohns Disease?”
- (2010) Walter Reinisch CURRENT DRUG TARGETS
- Clinical Experience with Adalimumab in a Multicenter Swiss Cohort of Patients with Crohn’s Disease
- (2010) Cristina Nichita et al. DIGESTION
- Adalimumab for Crohnʼs disease in clinical practice at Mayo clinic: The first 118 patients
- (2010) Jason M. Swoger et al. INFLAMMATORY BOWEL DISEASES
- Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure
- (2010) Ana Echarri et al. Journal of Crohns & Colitis
- Meta-analysis: the efficacy and safety of certolizumab pegol in Crohn’s disease
- (2009) L.-M. SHAO et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: the short-term and long-term efficacy of adalimumab following discontinuation of infliximab
- (2009) C. MA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
- (2009) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease
- (2009) Konstantinos Karmiris et al. GASTROENTEROLOGY
- Adalimumab for the treatment of fistulas in patients with Crohn's disease
- (2009) J-F Colombel et al. GUT
- Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab
- (2009) Waqqas Afif et al. INFLAMMATORY BOWEL DISEASES
- Efficacy of adalimumab for the management of Inflammatory Bowel Disease in the Clinical Setting
- (2009) Matthew W. Trinder et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience
- (2008) A. OUSSALAH et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Immunogenicity negatively influences the outcome of adalimumab treatment in Crohn’s disease
- (2008) R. L. WEST et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and complications of adalimumab treatment for medically-refractory Crohn’s disease: analysis of nationwide experience in Scotland (2004-2008)
- (2008) G. T. HO et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Early clinical experience with adalimumab in treatment of inflammatory bowel disease with infliximab-treated and naïve patients
- (2008) A. SWAMINATH et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab for Crohn’s disease with intolerance or lost response to infliximab: a 3-year single-centre experience
- (2008) A. OUSSALAH et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials
- (2008) Laurent Peyrin–Biroulet et al. Clinical Gastroenterology and Hepatology
- Successful induction of clinical response and remission with certolizumab pegol in Crohnʼs disease patients refractory or intolerant to infliximab: A real-life multicenter experience of compassionate use
- (2008) Silvio Danese et al. INFLAMMATORY BOWEL DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started